As of December 2024, Taiwan Advance Bio-Pharmaceutical has a market cap of $42.91M. This makes Taiwan Advance Bio-Pharmaceutical the world's 24594th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $41.67M | -10.91% |
2023 | $46.78M | -1.45% |
2022 | $47.47M | -6.78% |
2021 | $50.92M | -27.22% |
2020 | $69.96M | 36.00% |
2019 | $51.44M | -6.75% |
2018 | $55.17M | 6.30% |
2017 | $51.90M | -24.38% |
2016 | $68.63M | -32.34% |
2015 | $101.44M | -13.77% |
2014 | $117.63M | -27.78% |
2013 | $162.88M | -2.36% |
2012 | $166.81M | - |